Home Financial Markets Key Secret behind DermTech, Inc. (DMTK) surge in the Afterhours

Key Secret behind DermTech, Inc. (DMTK) surge in the Afterhours

DermTech, Inc. (NASDAQ: DMTK) stock was rising 27.83% to reach $18.28 in the aftermarket following the published the topline results of the TRUST Study, a non-invasive melanoma rule-out test using the Pigmented Lesion Assay. The TRUST study was intended to assess the long-term outcomes of the PLA negative results of pigmented skin lesions. It also serves to support further the 99% negative predictive value of the PLA. To determine the proportion of true negative lesions among all those that tested negative, the study protocol called for retesting PLA-negative lesions 12 to 24 months before each subject’s enrollment in the TRUST Study.

It helps identify melanoma in the early stages by detecting atypical pigmented lesions to help rule out the melanoma and the need for surgical procedures. The PLA identifies the LINC 518 and PRAME genes in a two-panel gene expression assay.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Read More

The TRUST study was conducted at five clinical sites in the U.S. that use the PLA to help manage atypical pigmented lesions in their clinical practice.

An assessment of a long-term follow-up cohort of 1,781 lesions with PLA negative testing in a 12 to 24 month period preceding the study’s start resulted in 302 lesions undergoing PLA testing and meeting the study’s prespecified enrollment target.

NPV and patient outcome measures for the full cohort of eligible lesions were established by prospectively reviewing charts for any melanoma diagnoses on the PLA tested lesion, late-stage diagnoses of melanoma, and melanoma mortality. There were no deaths or diagnoses of late-stage melanoma in the full cohort of 1,781 lesions. In total, ten lesions from the full cohort were diagnosed with melanoma after initial testing, four of which were Stage 0 lesions (in situ) and six Stage 1a lesions.

A subset of the full cohort, representing 1,233 lesions, confirmed follow-up evaluations on the PLA-negative test, and we calculated an NPV of 99.2% (CI95%= 98.5 – 99.6) from these evaluations.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aviat Networks, Inc. (AVNW) Stock Trending Up After Promising Financial Reports for Most Recent Quarter

Aviat Networks, Inc. (AVNW) stock prices were up 3.81% as of market close on May 5th 2021, bringing the price per share up to...

Regional Health Properties, Inc. (RHE) Stock Skyrocketing as Pandemic Regulations Ease Up

Regional Health Properties, Inc. (RHE) stock prices were up a staggering 90.39% during the course of the trading day on May 5th, 2021, bringing...

What Is Getting Alteryx (AYX) Stock To Soar In Premarket Trades?

The shares of Alteryx Inc. (AYX) rose 7.42% to trade at $82.06 in premarket trading at last check. To close Tuesday's trading session at...

Cocrystal Pharma, Inc. (COCP) Stock Skyrocketed Following Promising Updates on Covid-19 Drug Development

Cocrystal Pharma, Inc. (COCP) stock prices were up by a monumental 72.58% as of the market closing on may 4th 2021, bringing the price...

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) stock slumped in the afterhours trading session; here’s why

At last check, in the after-hours trading session, ADMP stock had slumped by-7.48% to $0.99. ADMP stock previously closed the session at $1.07 gaining...

Semileds Corp. (NASDAQ: LEDS) stock falls during pre-market. What has been happening?

Semileds Corp. (NASDAQ: LEDS) stock plunged by 7.41% at last close while the LEDS stock price continues to decline by 2.55% in the pre-market,...

10x Genomics (NASDAQ: TXG) stock slumped in the premarket trading session; here’s why

10x Genomics Inc. (TXG) stock plunged by-9.79% to the price of $165.0 in pre-market trading session. TXG stock has closed previous session at $182.90...

My Size Inc. (NASDAQ: MYSZ) stock plunged during after-hour trading, given no latest update

My Size Inc. (NASDAQ: MYSZ) stock surged by 24.87% at last close whereas the MYSZ stock price declined by 4.13% in the after hours...

Related News

My Size Inc. (NASDAQ: MYSZ) stock plunged during after-hour trading, given no latest update

My Size Inc. (NASDAQ: MYSZ) stock surged by 24.87% at last close whereas the MYSZ stock price declined by 4.13% in the after hours...

Etsy, Inc. (ETSY) Stock Continues to Trend Down After a Stellar 2020 Set Expectations Too High

Etsy, Inc. (ETSY) stock prices were down by a marginal 2.06% as of the market closing on May 5th, 2021, bringing the price per...

Cryoport Inc. (NASDAQ:CYRX) stock surged in the current trading session; here’s why

At last check, in the current trading session, CYRX stock surged by 11.28% to the price of $61.45. CYRX stock closed the previous session...

Amryt (AMYT) Stock Is Declining Before Market Open, I Wonder Why?

The price of Amryt Pharma plc (NASDAQ:AMYT) shares were down -8.88% to $11.7 at last check in premarket trading. AMRYT stock closed at $12.84...

Why DavidsTea Inc (DEA) stock surged in the after-market session on Tuesday after an early loss?

DavidsTea Inc (DEA) stock started the Tuesday, May 4 with negativity and lost 7.74% in the normal trading to close at $3.22 per share....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get Best Morning Financial Newsletter... 100% Free

Best stocks ideas

Analysts’ Upgrades & Downgrades

Insider Watchlist

Important Earnings

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!...100% Free

We do not sell or share your information with anyone.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.